Edition:
United Kingdom

Natco Pharma Ltd (NATP.NS)

NATP.NS on National Stock Exchange of India

790.20INR
23 May 2018
Change (% chg)

Rs36.15 (+4.79%)
Prev Close
Rs754.05
Open
Rs754.00
Day's High
Rs798.80
Day's Low
Rs753.20
Volume
303,465
Avg. Vol
311,325
52-wk High
Rs1,090.00
52-wk Low
Rs671.10

Latest Key Developments (Source: Significant Developments)

India's Natco Pharma March-Qtr Consol Profit Rises
Wednesday, 23 May 2018 

May 23 (Reuters) - Natco Pharma Ltd ::MARCH QUARTER CONSOL PROFIT 3 BILLION RUPEES VERSUS PROFIT 1.77 BILLION RUPEES YEAR AGO.MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 7.68 BILLION RUPEES VERSUS 5.78 BILLION RUPEES YEAR AGO.  Full Article

Natco Pharma Launches Tafnat, Tenofovir Alafenamide Tablets In India
Monday, 18 Dec 2017 

Dec 18 (Reuters) - Natco Pharma Ltd ::SAYS NATCO LAUNCHES TAFNAT, TENOFOVIR ALAFENAMIDE TABLETS, FOR TREATMENT OF CHRONIC HEPATITIS B, IN INDIA.  Full Article

Natco Pharma says Alvogen gets approval ‍​for generic oseltamivir phosphate powder for oral suspension
Friday, 3 Nov 2017 

Nov 3 (Reuters) - Natco Pharma Ltd :Marketing partner Alvogen gets final approval ‍​for generic equivalent to oseltamivir phosphate powder for oral suspension in U.S..  Full Article

India's Natco Pharma Sept-qtr consol profit up about 28 pct
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Natco Pharma Ltd :Sept quarter consol net profit 848 million rupees versus profit of 665 million rupees last year.Consensus forecast for Sept quarter consol net profit was 811.5 million rupees.Sept quarter consol revenue from operations 4.27 billion rupees versus 4.68 billion rupees last year.Says approved raising of funds worth up to 15 billion ‍​rupees‍​.Says approved equity participation not exceeding 75 million rupees in OMRV Hospitals Pvt.  Full Article

Natco Pharma Dec-qtr consol profit soars
Tuesday, 14 Feb 2017 

Natco Pharma Ltd : Dec quarter consol net profit 1.95 billion rupees . Natco pharma ltd consensus forecast for dec quarter consol net profit was 818.4 million rupees . Dec quarter consol net sales 6.43 billion rupees . Declared second interim dividend of inr 6 per share .Consol net profit in dec quarter last year was 369.3 million rupees as per ind-as; consol net sales was 2.75 billion rupees.  Full Article

Natco Pharma says Mylan invalidates two of Teva's Copaxone 40 mg/ml patents
Thursday, 25 Aug 2016 

Natco Pharma Ltd : Marketing partner Mylan invalidates two of Teva's Copaxone 40 mg/ml patents .  Full Article

Natco Pharma gets EIR for Chennai facility
Thursday, 25 Aug 2016 

Natco Pharma Ltd : Natco receives establishment inspection report for Chennai facility . Gets successful establishment inspection report for Chennai facility from FDA for February 2016 inspection .  Full Article

Natco Pharma June-qtr consol profit up about 70 pct
Tuesday, 9 Aug 2016 

Natco Pharma Ltd : June-quarter consol net profit 476.5 million rupees . June-quarter consol net sales 2.98 billion rupees . Consensus forecast for June-quarter consol net profit was 468 million rupees . Consol net profit in June-quarter last year was 280.7 million rupees as per Ind-AS; consol net sales was 2.16 billion rupees . Recommends interim dividend of 0.75 rupees per share .  Full Article

Natco Pharma gets FDA approval for generic Tamiflu
Thursday, 4 Aug 2016 

Natco Pharma Ltd : Natco receives final approval for generic Tamiflu .  Full Article

Natco Pharma gets USFDA nod for generic version of Glycopyrrolate tablets
Thursday, 23 Jun 2016 

Natco Pharma Ltd : Clarifies on news item "Natco Pharma gets USFDA nod for glycopyrrolate" . Received from US agent on June 22 intimating approval for generic version of glycopyrrolate tablets 1mg and 2mg from US FDA . Glycopyrrolate to be manufactured at co's finished dosage facility located at kothur, near hyderabad, India . Believes the product will not have any material or financial impact on its operations . The market potential of the product is not significant" .  Full Article

BRIEF-Natco Pharma Files ANDA to U.S. FDA For Sofosbuvir Tablets

* SAYS FILED AN ABBREVIATED NEW DRUG APPLICATION FOR SOFOSBUVIR TABLETS, 400MG, WITH U.S.‍​ FDA